Human amnion epithelial cells modulate early myeloid cell states after ischemic stroke

Background Inflammation contributes to brain injury and influences recovery after ischemic stroke. Stem cell-based therapies may improve stroke outcomes by regulating inflammatory and immune responses. Human amnion epithelial cells (hAECs) are one such candidate, but their mechanisms of action remain incompletely understood. In this study, we used single-cell RNA sequencing to investigate how intravenous administration of hAECs modulates the post-stroke immune microenvironment in a mouse model. Methods Male C57BL/6 mice underwent transient middle cerebral artery occlusion and received an intravenous injection of hAECs or vehicle 30 minutes after reperfusion. Therapeutic efficacy was assessed by measuring infarct volume and by neurological and behavioral testing. Ischemic brain tissue collected at 24 hours, 72 hours and 14 days after reperfusion was dissociated into single-cell suspensions for single-cell RNA sequencing and downstream analyses. Results Following systemic administration of DiO-labeled hAECs, DiO-associated signals were observed predominantly in the ipsilateral striatum of the ischemic brain. Dose–response analysis indicated that a dose of 1 × 10 6 hAECs per mouse was the most effective of the doses tested, as it reduced infarct volume and showed trends toward improved neurological outcomes after stroke. Single-cell RNA sequencing showed that hAEC treatment may reshape the post-stroke immune landscape by increasing the proportion of phagocytic microglia and Spp1 + remodeling macrophages at 24 hours. CellChat and NicheNet analyses implicated Spp1 – Cd44 as a candidate signaling axis linking phagocytic microglia and Spp1 + remodeling macrophages. Conclusion Intravenous hAEC treatment reduced infarct volume and may reshape the early post-stroke immune microenvironment by promoting distinct microglial and macrophage states. Spp1 – Cd44 was identified as a candidate signaling axis that may contribute to these immunomodulatory effects.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-19
DOI
https://doi.org/10.3389/fimmu.2026.1993058
Primary Topic
Neuroinflammation and Neurodegeneration Mechanisms
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Human amnion epithelial cells modulate early myeloid cell states after ischemic stroke

Yubo Wang, Chuanyu Zhang, Xiaoyan Li, Ling Zhang et al.
Frontiers in Immunology
Neuroinflammation and Neurodegeneration Mechanisms
article

Human amnion epithelial cells modulate early myeloid cell states after ischemic stroke

Yubo Wang, Chuanyu Zhang, Xiaoyan Li, Ling Zhang, Yujun Ye, Tian-jie Lyu, Zixiao Li
article en

Abstract

Background Inflammation contributes to brain injury and influences recovery after ischemic stroke. Stem cell-based therapies may improve stroke outcomes by regulating inflammatory and immune responses. Human amnion epithelial cells (hAECs) are one such candidate, but their mechanisms of action remain incompletely understood. In this study, we used single-cell RNA sequencing to investigate how intravenous administration of hAECs modulates the post-stroke immune microenvironment in a mouse model. Methods Male C57BL/6 mice underwent transient middle cerebral artery occlusion and received an intravenous injection of hAECs or vehicle 30 minutes after reperfusion. Therapeutic efficacy was assessed by measuring infarct volume and by neurological and behavioral testing. Ischemic brain tissue collected at 24 hours, 72 hours and 14 days after reperfusion was dissociated into single-cell suspensions for single-cell RNA sequencing and downstream analyses. Results Following systemic administration of DiO-labeled hAECs, DiO-associated signals were observed predominantly in the ipsilateral striatum of the ischemic brain. Dose–response analysis indicated that a dose of 1 × 10 6 hAECs per mouse was the most effective of the doses tested, as it reduced infarct volume and showed trends toward improved neurological outcomes after stroke. Single-cell RNA sequencing showed that hAEC treatment may reshape the post-stroke immune landscape by increasing the proportion of phagocytic microglia and Spp1 + remodeling macrophages at 24 hours. CellChat and NicheNet analyses implicated Spp1 – Cd44 as a candidate signaling axis linking phagocytic microglia and Spp1 + remodeling macrophages. Conclusion Intravenous hAEC treatment reduced infarct volume and may reshape the early post-stroke immune microenvironment by promoting distinct microglial and macrophage states. Spp1 – Cd44 was identified as a candidate signaling axis that may contribute to these immunomodulatory effects.

Frontiers in ImmunologyVol. 17
Capital Medical University (CN), Beijing Tian Tan Hospital (CN)
Neuroinflammation and Neurodegeneration Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon